Potassium and Epidiolex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Epidiolex (cannabidiol). Common drug interactions include pyrexia among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Epidiolex. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Epidiolex?

Epidiolex has active ingredients of cannabidiol. eHealthMe is studying from 18,763 Epidiolex users. Check the latest studies of Epidiolex.

On Aug, 06, 2026

49 people who take Potassium and Epidiolex together, and have interactions are studied.

Potassium and Epidiolex drug interactions.

What are the common drug interactions of Potassium and Epidiolex, by gender? *:

female:

Pyrexia (fever)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Hypervigilance
Tremor (trembling or shaking movements in one or more parts of your body)
Vomiting
Weight decreased
Arthralgia (joint pain)
Blood calcium decreased
Blood magnesium decreased
Chest pain

male:

Hospitalisation
Death
Drug ineffective
Dumping syndrome (a condition that can develop after surgery to remove all or part of your stomach or after surgery to bypass your stomach to help you lose weight)
Pneumonia
Pyrexia (fever)
Respiratory rate increased (excess breathing rate/min)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Sepsis (a severe blood infection that can lead to organ failure and death)
Sputum discoloured

What are the common drug interactions of Potassium and Epidiolex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Pyrexia (fever)
Drug hypersensitivity
Hospitalisation
Insomnia (sleeplessness)
Petit mal epilepsy (absence seizure)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Sleep disorder

10-19:

n/a

20-29:

Gastroenteritis (inflammation of stomach and intestine)
Hepatic fibrosis (scarring process that represents the liver's response to injury)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Thrombocytopenia (decrease of platelets in blood)
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Vomiting

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Arthralgia (joint pain)
Blood calcium decreased
Pain
Peripheral swelling
Pyrexia (fever)
Tooth disorder (tooth disease)
Vomiting
Abdominal discomfort
Bone pain
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 16 people, 32.65%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 14 people, 28.57%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 14 people, 28.57%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 6 people, 12.24%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 8.16%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.16%
Seasonal Allergy (allergic condition due to certain season): 3 people, 6.12%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 3 people, 6.12%
Chronic Respiratory Failure: 3 people, 6.12%
Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Epidiolex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously